NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being used in the development of novel bioanalytical assays at Illinois State University. The main application is the characterization of gold nanoparticles and differentiation between monodisperse samples from small numbers of aggregated materials.
Toronto-based Integran Technologies Inc. announced further advances in its "structural metal plating-on-polymer" technology (Nanovate NP) for enhancing fuel efficiency and reducing greenhouse gas emissions by enabling the cost-effective manufacture of lightweight transportation parts.
Particle Sciences, a leading drug delivery CRO, has teamed up with NETZSCH Premier Technologies, a leading manufacturer of wet milling and dispersing equipment, to provide drug developers with improved access to state-of-the-art pharmaceutical nanomilling equipment and full pharmaceutical development capabilities.
Building on earlier teamwork with Lewis University, Pall Corporation today announced that scientists from both organizations have expanded research into optimizing filtration technology for chemical mechanical planarization (CMP) operations, a critical step in the manufacture of microchips.
Kilopass Technology, Inc. (www.kilopass.com), a leading provider of semiconductor logic non-volatile memory (NVM) intellectual property (IP), announced today that it has received an $8 million funding from a major consumer electronics licensee.
Bruker today announced the launch of the new, scalable ContourGT-K 3D optical microscope for value-oriented, uncompromised bench-top metrology. Incorporating many of the advanced features of Bruker's flagship optical metrology products, the ContourGT-K delivers unsurpassed Z-axis resolution across all fields of view and superior 2D/3D imaging capability for non-contact profile, roughness and thickness measurements on a wide range of surfaces.
Starpharma Holdings Ltd today announced the results of an animal study which shows that a dendrimer-based formulation of doxorubicin was substantially more efficacious in treating secondary tumours of breast cancer (metastases) in lungs than the drug alone.
Skorpios Technologies, Inc., an innovator in silicon photonic technology, today announced demonstration of a full C-band tunable CMOS photonic laser manufactured in a commercial foundry utilizing its proprietary STAB process.